Showing results (21-30 of 240) with videos related to
Sort By:
Pageof 24
Molecular Pharmacology|October 1, 1994
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screenJ S Lee, K Paull, M Alvarez, et al.Blood|March 21, 1998
Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumorsL A Mickley, J S Lee, Z Weng, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomasS E Bates, C Y Shieh, L A Mickley, et al.The Journal of Biological Chemistry|October 25, 1989
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agentsL A Mickley, S E Bates, N D Richert, et al.Cancer Research|December 22, 1999
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cellsM Brangi, T Litman, M Ciotti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agentsT Fojo, M MenefeeCancer Research|January 19, 1999
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genesK Miyake, L Mickley, T Litman, et al.Cancer Research|September 7, 2012
Why RECIST works and why it should stay--counterpointAntonio T Fojo, Anne NoonanInternational Journal of Cancer|September 2, 1999
Molecular effects of paclitaxel: myths and reality (a critical review)M V Blagosklonny, T FojoJournal of Chemotherapy (Florence, Italy)|February 4, 2005
Platinums: extending their therapeutic spectrumF M Muggia, T FojoPageof 24